Cargando…
Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278867/ https://www.ncbi.nlm.nih.gov/pubmed/35857526 http://dx.doi.org/10.1126/sciadv.abn1958 |
_version_ | 1784746277047631872 |
---|---|
author | Xiao, Weiwei Chen, Wanli Wang, Yinggang Zhang, Cun Zhang, Xinchi Zhang, Siqian Wu, Wei |
author_facet | Xiao, Weiwei Chen, Wanli Wang, Yinggang Zhang, Cun Zhang, Xinchi Zhang, Siqian Wu, Wei |
author_sort | Xiao, Weiwei |
collection | PubMed |
description | Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedentedly acquired carotid arterial regeneration in rabbit model. Through single-cell RNA sequencing analysis and cell tracing studies, a subset of endothelial progenitor cells, myeloid-derived CD93(+)/CD34(+) cells, was identified as the main contributor to final endothelium regeneration. To conclude, DTβ4-inspired porous 3DVGs present adjustable physical properties, superior anticoagulating, and re-endothelializing potentials, which leads to the regeneration of small-caliber artery, thus offering a promising tool for vessel replacement in clinical applications. |
format | Online Article Text |
id | pubmed-9278867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92788672022-07-29 Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization Xiao, Weiwei Chen, Wanli Wang, Yinggang Zhang, Cun Zhang, Xinchi Zhang, Siqian Wu, Wei Sci Adv Biomedicine and Life Sciences Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedentedly acquired carotid arterial regeneration in rabbit model. Through single-cell RNA sequencing analysis and cell tracing studies, a subset of endothelial progenitor cells, myeloid-derived CD93(+)/CD34(+) cells, was identified as the main contributor to final endothelium regeneration. To conclude, DTβ4-inspired porous 3DVGs present adjustable physical properties, superior anticoagulating, and re-endothelializing potentials, which leads to the regeneration of small-caliber artery, thus offering a promising tool for vessel replacement in clinical applications. American Association for the Advancement of Science 2022-07-13 /pmc/articles/PMC9278867/ /pubmed/35857526 http://dx.doi.org/10.1126/sciadv.abn1958 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Xiao, Weiwei Chen, Wanli Wang, Yinggang Zhang, Cun Zhang, Xinchi Zhang, Siqian Wu, Wei Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization |
title | Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization |
title_full | Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization |
title_fullStr | Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization |
title_full_unstemmed | Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization |
title_short | Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization |
title_sort | recombinant dtβ4-inspired porous 3d vascular graft enhanced antithrombogenicity and recruited circulating cd93(+)/cd34(+) cells for endothelialization |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278867/ https://www.ncbi.nlm.nih.gov/pubmed/35857526 http://dx.doi.org/10.1126/sciadv.abn1958 |
work_keys_str_mv | AT xiaoweiwei recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization AT chenwanli recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization AT wangyinggang recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization AT zhangcun recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization AT zhangxinchi recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization AT zhangsiqian recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization AT wuwei recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization |